The Telematics-based Auto Insurance Market Worth US$ 13,998.3 Million by 2033 Globally, at a CAGR of 18.7%, Says Future Market Insights, Inc.

The market is expected to progress at a CAGR of 18.7% from 2023 to 2033. The telematics-based auto insurance market is predicted to be worth US$ 2,513.9 million in 2023 and rise to US$ 13,998.3 million by 2033. The global industry was expanding at a CAGR of 16.6% from 2018 to 2022.

Governments want to develop the automotive industry by implementing cutting-edge telematics in cars. This is one of the key drivers of global market expansion. However, on-board Diagnosis (OBD)-ll dongles offer possible entry points that hackers use to steal information, cars, and remotely operate vehicles.

The use of various systems in the insurance telematics industry increases the risk of malware and virus assaults. This may hurt the market internationally.

Potential Market Opportunity

AI, IoT, and 5G technologies are speeding innovation in the automotive sector and opening up new possibilities for enhanced user experiences and data monetization. Additionally, businesses have tremendous opportunities to exchange data from telematics devices with numerous parties. Moreover, gain insightful data on a large scale by implementing telematics devices.

Key Takeaways

  • By 2033, the telematics-based auto insurance market in the United Kingdom is likely to expand, with a CAGR of 18.2%.
  • In 2022, the United States dominated the telematics-based auto insurance sector, with a share of 18.5%.
  • The telematics-based auto insurance market was significantly expanding, with a size of US$ 2,146.8 million in 2022.
  • By 2033, the telematics-based auto insurance market in China is likely to expand, with a CAGR of 17.7%.
  • In 2022, Germany expanded the telematics-based auto insurance business, with an expected share of 7.6%.
  • The market is expected to grow at a US$ 4,204.02 million valuation by 2026, with a rise in passenger vehicles.
  • By 2033, India is projected to expand significantly in the telematics-based auto insurance market, with a share of 19.3%.
  • Japan’s telematics-based auto insurance industry share expanded significantly, with a 9.6% share in 2022.
  • In 2022, the passenger car dominated the market with a share of 48.5%. It is anticipated to control the market by 2033 in terms of vehicle type.
  • Based on vehicle age, used vehicles dominated the market with a share of 54.5% in 2022.

Effective Approaches by Key Players

Insurance regulators are used to selling and delivering packaged products to families both directly through digital and ‘captive agent’ channels. As well as indirectly through agencies, brokers, and other intermediaries. This practice necessitates a huge marketing and commission investment.

Telematics-based auto insurance service providers are looking for investment opportunities. To support their marketing and technological base.

Recent Developments

  • Snapshot ProView, a voluntary UBI and fleet management program for small business owners, was introduced by Progressive Corporation. Based on the type of vehicle and the nature of business use, many clients save 8%. Whereas, others can even save up to 18%, for their initial term.

  • Driven Telematics teamed up with Cambridge Mobile Telematics (CMT) in October 2022. To assist teen drivers in increasing driving safety and lowering their auto insurance costs. The brand-new Driven app, which is available for free, offers families insights into their driving habits and a driving score. So they can compare insurance and keep premiums affordable.

Get the PDF Sample Copy of this report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17166

Key Segments

By Vehicle Type:

  • Passenger Cars
  • Commercial Vehicles
  • Two-wheelers)

By Technology:

  • OBD-I

  • Hybrid

  • Smartphone

  • Black-box

By Deployment:

  • On-Premise

  • Cloud

By Type:

  • Pay-As-You-Drive (PAYD)
  • Pay-How-You-Drive (PHYD)
  • Manage-How-You-Drive (MHYD)

By Vehicle Age:

  • New Vehicle
  • Used Vehicle

By Organization Size:

  • Large Enterprises

  • Small & Medium-sized Enterprises

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East & Africa (MEA)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Companion Animal Drugs Market to Reach USD 59.2 Billion by 2033 at a 4.4% of CAGR

Companion Animal Specialty Drugs Market
Companion Animal Specialty Drugs Market

The global companion animal drugs market, valued at USD 36.7 billion in 2022, is forecasted to grow at a compound annual growth rate (CAGR) of 4.4%, reaching a market valuation of USD 59.2 billion by the end of 2033.

This growth is fueled by the rising adoption of companion animals, increasing awareness of pet health, and the expanding availability of advanced veterinary drugs. As pet owners seek to ensure the health and well-being of their animals, the demand for effective medications, including those for chronic conditions, preventive care, and treatments for common ailments, is on the rise.

Pet or companion animals are given companion animal medications to keep them healthy and protected from infections and other health problems. When an animal undergoes surgery, a companion animal veterinarian administers medications to treat wounds, diagnose various conditions, etc.

Companion animal medications are therefore crucial for keeping pets healthy and protecting the entire family who is caring for them from any health risks those pets may pose. Various companion animals, such as dogs, cats, horses, etc., frequently use companion animal drugs.

During the projected period, market expansion is anticipated to be fueled by an increase in measures taken by the public and private sectors to support the promotion of animal health. One such multi-organizational cooperation initiative is the One Health Initiative. These organizations include the American Veterinary Medical Association (AVMA), Food and Agriculture Organization (FAO), World Organization for Animal Health (OIE), and others.

By preserving animal health, it aims to preserve public health by preventing and controlling zoonotic infections. It is carried out through putting into effect the proper policies at the national, regional, and international levels.

According to Future Market Insights, the global market has huge growth potential due to the growing trend of adopting pet animals.

Competitive Landscape

The companion animal drugs market is competitive and has several established companies. Key companion animal medicine suppliers employ techniques like mergers, acquisitions, collaborations, and alliances to expand their businesses. Players in both the global and local markets profit from a sizable distributor-marketing network.

Recent Market Developments

  • In 2020, Virbac introduced STELEFONTA, a ground-breaking injectable therapy for canine mast cell tumors, the most prevalent form of skin cancer in dogs, which has a tailgate and an extremely high tumor eradication rate.
  • In June 2020, Merck committed USD 100 million to improvements and facility expansion at its De Soto, Kansas, USA manufacturing facility. The vaccine manufacturing plant was also expanded at this location, increasing its capacity for production.

Similarly, recent developments have been tracked by the team at Future Market Insights related to companies in companion animal drugs space, which are available in the full report

Key Companies Profiled

  • Zoetis Inc.
  • Merck & Co, Ltd.
  • Bayer AG
  • Elanco
  • Boehringer Ingelheim GmbH (Merial)
  • Virbac Animal Health
  • Ceva Santè Animale

A Full Report Overview

Key Segments Covered in Companion Animal Drugs Industry Research

Product:

  • Antibiotics
  • Anti-inflammatory
  • Parasiticides
  • Heartworm
  • Behavioral Products
  • Nutritional Products
  • Skin Care Products
  • Vaccines

Distributional Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies and Drug Stores

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Respiratory Inhaler Devices Market Set to Reach USD 60,114.7 Million by 2033 with a CAGR 4.90%

Respiratory Inhaler Devices Market
Respiratory Inhaler Devices Market

The global respiratory inhaler devices market, valued at USD 37,258.5 million in 2023, is projected to grow at a compound annual growth rate (CAGR) of 4.90%, reaching an estimated valuation of USD 60,114.7 million by 2033.

The market’s expansion is primarily driven by the increasing global prevalence of respiratory disorders, including asthma, chronic obstructive pulmonary disease (COPD), and other related conditions. As these disorders become more widespread, there is a growing demand for effective treatment options, which is fueling the adoption of respiratory inhaler devices. Additionally, advancements in inhaler technologies, such as smart inhalers and more efficient delivery systems, are expected to further drive product demand by offering better patient compliance and improved therapeutic outcomes.

The rising prevalence of respiratory disorders across the globe is driving the growth in the respiratory inhaler device market. The surging demand for treatment options for respiratory disorders and access to well-developed technologies are further expected to the product demand.

In addition, the ever-increasing elderly population, growing awareness regarding pulmonary diseases and rise in healthcare expenditure are sculpting growth in the market. Moreover, the rise in air pollution level throughout the globe is fuelling the product demand.

Growing cases of forest fire, increasing number of automobiles and growing number of factories are fostering growth in the market. Furthermore, rising use of fluoroscopy in pain management caused due to respiratory disorders will boost the product sales.

The rapid technological advancements along with several initiatives undertaken by governments to stop respiratory diseases will open up new avenues for market expansion. The growth will be driven by spreading awareness regarding the symptoms of respiratory disorders and availability of new treatment.

2018 to 2022 Respiratory Inhalers Devices Demand Analysis vs. Forecast 2023 to 2033

The market for respiratory inhaler devices was worth US$ 30,556.81 million in 2018, while growing at a CAGR of 3.95% during the historical period.

Over the years, metered dose inhalers are increasingly being adopted for the treatment of various respiratory disorders like asthma and COPD. The ability of these inhalers to deliver the right amount of medication fast is helping the market to grow. Various governments in developed nations are also supporting the production of tech superior inhaler devices due to their massive demand among the populace. Both of these factors will positively affect the market growth in the coming years.

Also, the demand for respiratory inhalers is expected to witness an upswing in the coming years. There is rapid surge in demand for dry powder inhalers’s due to prevalence of emphysema, bronchitis, and other disorders etc.. The presence of these disorders amongst teenagers and adults is pushing the pharmaceutical companies to work on research and development to innovative new formulation technologies.

The advancements in technology is further expected to drive the market growth. Rise in advancements in the advance portable inhalation technology will aid the market growth.

The expansion of healthcare sector’s and its ability to deliver affordable drugs is providing a strong stimulus for market expansion. Increasing government effors to provide affordable and accessible medicine is a significant factor that will contribute to market growth in the next ten years.

Considering these factors and new developments, the revenue growth of respiratory inhalers devices market is projected to be worth USD 60114.7 million by end of the forecast period, while exhibiting a CAGR of 4.90 %.

Market Competition

The Respiratory Inhalers devices market is extremely competitive and consists of numerous key industry players. These players are innovating novel delivery systems for treating respiratory disease. This is expected to propel Respiratory Inhalers devices market. The key industry players are:

  • AstraZeneca
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc.
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

Some recent developments in the market are:

Key market players are leveraging on inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to enhance their product portfolio. This is expected to fuel the global Respiratory Inhalers devices market.

  • In December 2020, OMRON Healthcare introduced WheezeScan for children suffering from Asthma to accurately detect the presence of wheezing in young children and to remove the unpredictability of potential misdiagnosis.
  • In March 2021, in the United States and Mexico, AstraZeneca PLC initiated a Phase III clinical trial to assess the effectiveness and safety of budesonide/glycopyrronium/formoterol inhalers in adolescents and adults with chronic asthma inadequately controlled with standard care. The will trial will be completed in September 2023.
  • In May 2022, Alkem intorduced its first inhalation device, Innohaler, for asthma and COPD and asthma patients.

Grab Your Complete Report Instantly

Key Segments Profiled in the Respiratory Inhalers Devices Industry Survey

By Product:

  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Nebulizers
    • Compressed Air Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

By Technology:

  • Manually Operated Inhaler Devices
  • Digitally Operated Inhaler Devices

By Disease Indication:

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Pulmonary Arterial Hypertension
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Optical Transceivers Market 2023 Future Analysis, Demand by Regions and Opportunities with Challenges 2033

According to a recent FMI analysis, the global optical transreceivers market is expected to grow at a high CAGR between 2022 and 2032. The report’s purpose is to identify micro and macroeconomic factors that will drive optical transreceiver sales over the next decade.

The study includes a comprehensive analysis of the market forecast, including governing factors, and covers the market’s breadth across numerous categories, including form factor, fiber type, data rate, application, and region. It also offers insights into important market dynamics and their impact on seven regions and more than 20 countries.

Advent Of Industry 4.0 Technology To Create New Growth Avenues For The Optical Transreceivers Market

Industrial sector is witnessing revolution as manufacturers across the world are extensively emphasizing towards adopting incorporating advanced automation, this is commonly being referred to as Industry 4.0.

With the emergence of industry 4.0, manufacturing facilities are emphasizing on adopting novel technologies such as artificial intelligence, smart manufacturing, internet of things (IOT), and machine learning among others. This is expected to create lucrative growth opportunities in the Optical Transreceivers market.

Additionally, increasing government emphasis building a better manufacturing sector and integration of augmented and virtual reality using smart equipment to enhance the output is estimated to propel the demand in the market for coming years.

Key Optical Transreceivers Market Takeaways And Projections

  • The U.S. is estimated dominate the Optical Transreceivers market in North America, accounting for the largest share in the region through 2032.
  • Germany is projected to account for a significant share in the Europe market over the assessment period.
  • China is forecast to hold the lion’s share the East Asia market, projecting the fastest growth in the region between 2022 and 2032
  • India is anticipated to emerge as a highly remunerative market in South Asia, accounting for the largest sales during the forecast period.
  • In terms of By Form factor, fiber type, data rate, application & Region expected to contribute maximum sales in the market, expanding at a robust CAGR during the coming decade.

Report Benefits & Key Questions Answered

  • Optical Transreceivers Historical Market Outlook:Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities and challenges. It studies their impact on the market over the previous assessment period 2017-2021. The report provides crucial insights to market players to capitalize on opportunities and counter challenges.
  • Optical Transreceivers Demand-Supply Assessment:A latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Optical Transreceivers market. As per the survey, Optical Transreceivers sales will project steady growth over the forecast period.
  • Optical Transreceivers Market Structure Analysis:The report provides detailed information about tier analysis and the market concentration of the key players in the Optical Transreceivers market. It also categories market players as per Tier 1, Tier 2, and Tier 3 and their market presence in terms of their market share and product portfolio.
  • Optical Transreceivers consumption by Demographics:The report published by FMI provides consumption by demographics analysis to assist the market players in formulating their marketing strategies on the basis of purchasing power of the customers. It examines changes in consumer behavior and also studies its effect on the demand for Optical Transreceivers.
  • Optical Transreceivers market Trend Analysis:FMI’s market trend analysis provide detailed insights into current and upcoming trends in the industrial automation industries. It also assist the industry players to identify potentials trends to capitalize on them.

Competitive Landscape Analysis

The latest study by FMI on the global Optical Transreceivers market gives an exhaustive analysis on the development of existing as well as emerging market players. The detailed analysis on the competitive landscape gives the reader an unbiased view on the latest strategies adopted by leading Optical Transreceivers market players.

The report also profiles some of the leading players operating in the Optical Transreceivers market including:

  • II-VI Incorporated
  • Accelink Technologies
  • Arista Networks Inc.
  • Broadcom Inc.
  • Cisco Systems, Inc.
  • Fujitsu Optical Components Limited
  • Huawei Technologies Co., Ltd.
  • NEC Corporation
  • ZTE Corporation
  • Sumitomo Electric Industries
  • Applied Optoelectronics
  • Infinera
  • Eoptolink
  • Perle Systems
  • Fiber Optic Communications, Inc. (FOCI).

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

USA Compounding Pharmacies Market to Reach USD 23,430.35 Million by 2033 at a 7.80% of CAGR

USA Compounding Pharmacies Market
USA Compounding Pharmacies Market

The USA compounding pharmacies market was valued at USD 10,326.0 million in 2022, and is expected to reach USD 11,099.0 million by the end of 2023. Over the next decade, the market is projected to experience robust growth, with a compound annual growth rate (CAGR) of 7.8%, ultimately reaching a market value of US$ 23,430.35 million by 2033.

This growth is driven by the increasing demand for personalized medications tailored to individual patient needs, especially in cases of complex conditions that require specialized treatments. Compounding pharmacies provide unique solutions, including customized dosages, alternative delivery forms, and the ability to address specific allergies or sensitivities, which are fueling their growing adoption across the healthcare sector.

Key Market Trends and Highlights

  • Growing demand for personalized medications: Increasing patient demand for custom pharmaceuticals that meet their specific demands is propelling market expansion.
  • Expanding veterinary compounding: The market for specialized pet pharmaceuticals is expanding as a result of rising consumer demand.
  • Safety is ensured via regulatory oversight: Standards for quality and patient safety are upheld by strict rules and monitoring.
  • Bioidentical hormone therapy: Growing interest in personalized hormone therapies, particularly for the management of menopause.
  • Geriatric and pediatric care: There is a market niche for tailoring drugs to certain age groups.
  • Filling up drug shortages: Compounding pharmacies in the USA fill the gap left by the lack of commercially available drugs.
  • Enhanced pain management: Tailored pain treatment products are a rising market segment.

USA Compounding Pharmacies Market Key Drivers

  • The market is expanding as a result of the rising demand for customized medication. By modifying drugs to meet the specific needs of each patient, personalized medicine seeks to enhance the safety and efficacy of pharmaceuticals.
  • Patients with particular needs, such as those with allergies or intolerances to specific compounds, those who need treatment for uncommon orphan illnesses, and others, need compounded drugs that are specially formulated for their circumstances.
  • Certain drugs that have been discontinued for primarily commercial reasons are still accessible through compounded pharmacies. For instance, the USA. FDA maintains a list of around 206 drugs that have been withdrawn from the market, including budesonide as well as ursodiol capsules, which compounded drugs may easily replace.
  • The need for compounded drugs has grown as a result of the lack of commercially available treatments, particularly for chronic illnesses, which has helped the industry expand.
  • The bulk of the reported medicine shortages were for drugs used to treat cardiovascular conditions. Pharmaceutical compounding is frequently viewed as the best way to deal with the pharmaceutical shortage and fill any gaps that result from it.
  • For instance, the USA Food and Drug Administration (FDA) published a paper titled Drug Shortages: Root Causes and Potential Solutions. In 2019, hospitals stated that they had altered patient care or postponed therapy due to medication shortages, and 36.6% said that they had to postpone routine or emergency operations.
  • Such a situation encourages the usage of easily accessible compounded drugs, which is anticipated to fuel the expansion of the compounding pharmacies market in the United States.

Key Companies Profiled

  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services Inc.
  • Hoye’s Pharmacy
  • Vertisis Custom Pharmacy
  • Smith Caldwell Drug Store
  • Sixth Avenue Medical Pharmacy
  • Cantrell Drug Company
  • Clinigen Group, Dougherty’s Pharmacy
  • Fagron N.V.

Get the Comprehensive Full Report Now

Segmentation Analysis of the USA Compounding Pharmacies Market

By Product:

  • Oral Medication
    • Solid Medication
      • Capsules
      • Tablets
      • Mixtures
      • Lollipops
      • Lozenges
    • Liquid Medication
      • Syrup
      • Solution/Liquid
      • Emulsion
      • Suspension
    • Topical Medication
      • Gels
      • Ointments
      • Creams
      • Lotions
  • Injectable
  • Mouthwashes
  • Nasal
  • Ocular
  • Otic
  • Suppositories and Enemas

By Pharmacy Type:

  • 503A Pharmacy
  • 503B Pharmacy

By Application:

  • Adults
  • Pediatrics
  • Geriatrics
  • Veterinary

By Therapeutic Area:

  • Hormone Replacement Therapy
  • Pain Management
  • Dermatology
  • Oncology
  • Hematology
  • Dental
  • Others

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Mobile Broadband Modem Market to Exceed US$ 48.0 billion by 2032 as Trend for Work from Home Gains Impetus Globally | Future Market Insights, Inc.

By 2032, it is anticipated that the market for mobile broadband modems would be worth US$ 48.0 billion. From 2022 to 2032, it is projected to exhibit a moderate CAGR of 9.9%. In 2022, the market was valued at over US$ 18.6 billion.

More people than ever before have started working from home or other remote locations over recent years. This has accelerated the trend toward remote work. Mobile broadband modems offer a dependable method for remote employees to maintain an internet connection and access corporate systems & apps from any location.

Consumers and organizations can now use the internet more affordably thanks to the recent sharp decline in the price of mobile data. As more people can nowadays afford the price of data plans and equipment, it has contributed to growth in the mobile broadband modem industry.

Get a Sample PDF of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-17148

In the years following the pandemic, about 80% of people are working from home at least three times per week, up from the 52% who did so before the outbreak.

Around the world, 16% of businesses now allow employees to work permanently from home. Sales of mobile broadband modems are anticipated to rise over the assessment period as remote work expands globally.

Applications involving the internet of things (IoT) frequently use mobile broadband modems. Wireless networks are often used to link IoT devices to the internet. These gadgets can be connected to the internet in a dependable and adaptable manner using mobile broadband modems.

In remote or difficult-to-reach areas without fixed-line broadband connections, these modems can also be employed for IoT applications. In the event of a primary internet outage, these can be utilized in IoT to provide a backup internet connection.

Mobile broadband modems can be crucial for internet of things (IoT) applications that need constant communication, including security systems or industrial monitoring software.

In 2019, there were around 8.6 billion IoT connected devices; by 2022, there will be over 13 billion connected devices. By 2030, it is anticipated that there will be about 29 billion linked IoT devices worldwide. Mobile broadband modem demand is anticipated to soar due to rising IoT demand globally.

Picture background

Key Takeaways from Mobile Broadband Modem Market Study:

  • The global mobile broadband modem market exhibited a CAGR of 13.1% from 2017 to 2021.
  • The United States mobile broadband modem industry is expected to be worth US$ 7.6 billion by 2032.
  • The United Kingdom mobile broadband modem industry is set to reach a valuation of US$ 1.3 billion in 2032.
  • The standalone mobile broadband modem by type is likely to broaden at a CAGR of 9.8% from 2022 to 2032.
  • Based on application, the business segment is predicted to accelerate at a CAGR of 9.6% from 2022 to 2032.

“More people are adopting mobile data services to access the internet while on the go as a result of the widespread use of mobile devices such as smartphones and tablets. There is now a higher need for mobile broadband modems that can offer dependable and quick internet connectivity, presenting growth opportunities to manufacturers.” – says a lead analyst at Future Market Insights (FMI)

Competitive Landscape

To stay ahead of the competition, key businesses are investing in enhancing the speed and dependability of their products. It involves upgrading hardware & software, network technology optimization, and signal reception.

A few other businesses are collaborating with neighborhood groups to broaden their market reach and provide customers with more benefits. To develop complete solutions, it involves working with internet service providers, hardware manufacturers, and software firms.

For instance,

  • In February 2023, ArcelorMittal France announced the implementation of 5G Steel, which is the most extensive 4G/5G network in an industrial setting, in collaboration with Orange Business Services and Ericsson. The initiative, which is part of the France Relance plan to stimulate the economy, has been launched, and is now facilitating the implementation of initial industrial use cases at the ArcelorMittal site.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global General Anesthesia Drugs Market to Reach USD 6,898.4 Million by 2033 at a 3.3% of CAGR

General Anesthesia Drugs Market
General Anesthesia Drugs Market

The global general anesthesia drugs market, valued at USD 4,978.1 million in 2023, is poised for steady growth, with projections indicating a compound annual growth rate (CAGR) of 3.3% between 2023 and 2033. By the end of the forecast period, the market is expected to surpass USD 6,898.4 million.

This growth is driven by continued demand for general anesthesia drugs in various surgical and medical procedures, as well as advancements in anesthesia technologies that enhance patient safety and recovery. As healthcare systems evolve and surgical procedures become more complex, the need for effective and reliable anesthesia drugs remains critical, ensuring the market’s steady expansion.

Key Highlights

  • Given their widespread use in surgeries and increasing cases of cardiovascular disease, the general anesthesia drugs market is poised for considerable growth. Advancements in targeted drugs and drug delivery technology exceedingly support this.
  • North America’s significant market share and projected continued dominance over the forecast period. This can be attributed to an upsurge in chronic disease prevalence, a boost in the volume of general anesthesia drug approvals, and the presence of general anesthesia drug industry players.
  • In terms of CAGR, the Asia Pacific is expected to demonstrate significant growth. This is driven by the increasing prevalence of cardiovascular diseases, a rise in surgical procedures, and a growth in healthcare expenditures.
  • Manufacturers are prioritizing the development of innovative aesthetic drugs for market sustainability. They are also frequently pursuing licensing arrangements to ensure the global accessibility of their products.

Competitive Landscape of the General Anesthesia Drugs Market

The entire general anesthetic drugs market is extremely fragmented, featuring multiple manufacturers. Companies are employing different tactics such as mergers and acquisitions, partnerships and collaborations, and new product releases to match consumer demand and boost their target audience.

Recent Developments in the General Anesthesia Drugs Market

  • In June 2023, Milla Pharmaceuticals’ generic variant of Precedex, dexmedetomidine hydrochloride injection 4mcg/mL in 50mL and 100mL, was officially approved by the United States Food and Drug Administration.
  • In June 2023, Hikma Pharmaceuticals PLC introduced Midazolam injection pouches containing 0.9% Sodium Chloride (NaCl) in 50mg/50mL and 100mg/100mL dosages. The medicine has been approved for constant intravenous infusion for sedation of ventilated and oxygen-deprived adults, pediatric, and infants as part of anesthesia or during therapy in a critical care environment in the United States.
  • In January 2022, Halocarbon Life Sciences leased Isoflurane USP Inhalant Anesthetic and Sevoflurane USP Inhalant Anesthetic to Dechra Pharmaceuticals. These inhalation anesthetic solutions are utilized in both human and animal medicine.

Key Companies Profiled in the General Anesthesia Drugs Market

  • Baxter International Inc.
  • AstraZeneca
  • AbbVie Inc.
  • B. Braun Melsungen AG
  • Fresenius SE & Co. KgaA
  • Pfizer
  • Hospira Inc.
  • Aspen Pharmacare Holdings Limited
  • Hikama Pharmaceuticals plc
  • Abbott Laboratories
  • Avet Pharmaceuticals, Inc
  • Piramal Enterprises Limited
  • Par Pharmaceutical
  • Teva Pharmaceuticals
  • Viatris/Mylan
  • Novartis AG
  • GlaxoSmithKline plc
  • Gilead Sciences, Inc.
  • Sanofi
  • Akorn
  • Apotex
  • Heritage Pharmaceuticals Inc.

Access the Full Report

Key Market Segments Covered in General Anaesthesia Drugs Industry Research

General Anesthesia Drugs Market By Drug Class:

  • Propofol
  • Sevoflurane
  • Dexmedetomidine
  • Desflurane
  • Remifentanil
  • Midazolam
  • Others – (Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental, etc.)

General Anesthesia Drugs Market By Route of Administration:

  • Intravenous Anesthesia
  • Inhaled Anesthesia

General Anesthesia Drugs Market By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

General Anesthesia Drugs Market By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Global Workflow-as-a-service Market to be Worth USD 13,668.5 Million by 2033: Future Market Insights, Inc.

According to Future Market Insights (FMI), the global workflow-as-a-service market size is expected to surge with a CAGR of 9.7% during the forecast period from 2023 to 2033. The market is estimated to reach a valuation of USD 13,668.5 million by the end of 2033. It is likely to be valued at USD 5,455.1 million by 2023.

A type of cloud-based technology called workflow-as-a-service (WaaS) enables businesses to manage and automate their business processes. WaaS is a platform for creating, deploying, and managing workflows that automate difficult operations and procedures.

Document approval, customer onboarding, and data integration are a few of these duties. WaaS provides a variety of advantages such as cost reductions, scalability, and increased effectiveness. About 55% of the market for workflow solutions is occupied by workflow-as-a-service.

Request a Sample Copy of This Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17139

WaaS enables businesses to easily and quickly scale their workflow requirements up or down. With this functionality, they don’t need to spend money on new gear or software. It enables businesses to react swiftly to shifts in the market or shifts in demand.

WaaS providers must maintain the platform’s security and compliance, which can be a considerable burden for businesses. Organizations can take advantage of the security and compliance protections the supplier has in place by employing WaaS.

Organizations must be able to give their employees access to their workflow processes from any location, as remote work will become more prevalent by 2033. As long as they have an internet connection, WaaS enables employees to access their processes from any location and on any device.

WaaS also automates a number of manual tasks, helping businesses to streamline their workflow procedures and shorten turnaround times. It might result in more effectiveness and productivity.

WaaS is easily scalable to accommodate the requirements of companies of all sizes, from small start-ups to huge corporations. They can also flourish and adjust to shifting market conditions without having to make substantial investments in infrastructure or IT personnel. Businesses can hence employ a cloud-based WaaS provider with a pay-as-you-go approach that enables them to scale up or down as necessary.

Development of advanced technologies, including robotic process automation (RPA), machine learning, and artificial intelligence (AI) is expected to further advance the workflow-as-a-service industry. Market expansion is also set to be driven by rising demand for workflow-as-a-service solutions to optimize corporate processes.

Key Takeaways from Workflow-as-a-service Market Study

  • By business workflow, the IT & operations segment is estimated to expand at a CAGR of 2% in the next ten years.
  • In terms of business workflow, the sales & marketing category is likely to witness a CAGR of 5% in the forecast period.
  • By region, South Asia and Pacific is estimated to elevate at a CAGR of 0% over the assessment period.
  • China workflow-as-a-service industry is anticipated to surge at a CAGR of 2% in the next ten years.
  • India workflow-as-a-service market is likely to exhibit a CAGR of 0% during the forecast period.

Request Customization of the Report:
https://www.futuremarketinsights.com/customization-available/rep-gb-17139

“Rising need for cloud-based services and growing demand for automation are likely to fuel workflow-as-a-service sales. Increasing desire for cost-effective solutions is another prominent factor that is anticipated to aid demand. Rising adoption of digital transformation efforts by organizations is set to boost growth in the market for workflow-as-a-service by 2033.” – Says a lead analyst at Future Market Insights (FMI)

Competitive Landscape

With several vendors offering a wide range of goods and services, the workflow-as-a-service industry is extremely competitive and fragmented. To keep up with the tremendous demand, businesses would constantly innovate, spend money on research & development, and launch new goods & services.

For instance,

  • In September 2021, to help users improve customer and service agent experiences, Salesforce revealed that new contact center technologies and AI-powered processes will be added to its Service Cloud platform.

The processes, which will be integrated into the Customer 360 platform, will make use of automated technology. It would help assist customer care agents in responding to incidents, get rid of tedious chores, and streamline the case routing process within an organization.

Key Players

  • IBM Corporation
  • Micro Focus
  • Ricoh
  • TrackVia
  • Flokzu
  • Bitrix
  • Zoho
  • Integrify
  • KISSFLOW
  • VIAVI Solutions
  • Cflow
  • ProcessMaker
  • Nintex

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

East Asia Automotive Semiconductors Market is expected to grow at a high CAGR of 12.1% from 2023 to 2033 – FMI

East Asia Automotive Semiconductors Market

According to Future Market Insights (FMI), the East Asia automotive semiconductors market is predicted to grow at a CAGR of 12.1% from 2023 to 2033. The market is expected to be valued at $26,742.4 million by the end of 2033. It is expected to exceed a worth of $9,467.1 million by 2023.

Automotive semiconductors are important electronic components found in cars and trucks in East Asia. These semiconductors are used to regulate, safeguard, and control automotive electrical systems.

These also make it possible for cars to run effectively and safely. Microcontrollers, power transistors, integrated circuits, memory chips, and sensors are a few types of automotive semiconductors that are frequently utilized in East Asia. The industry holds a 42% market share in East Asia for vehicle electronics.

The car industry is seeing a rapid development of safety features, which is likely to accelerate tremendously in the next ten years. In order to deliver a safer and more convenient driving experience, automakers are set to adopt semiconductors. Rising adoption of self-driving cars is also projected to change the demand for automotive semiconductors across East Asia. It is further set to compel original equipment manufacturers (OEMs) to seek in-house designs.

Increased emphasis on autonomous vehicles (AVs) has already impacted demand patterns for automotive semiconductors in the region. Sales of specialized silicon chips suited to specific applications are expanding rapidly.

Only a few semiconductor vendors provide these bespoke chips. Various OEMs are increasingly creating them in-house to decrease development schedules and gain more control. With the growing need for custom silicon, more OEMs might follow suit.

Key Takeaways from East Asia Automotive Semiconductors Market Study:

  • By product, the integrated circuits (IC) segment is anticipated to expand at a CAGR of 12.4% over the forecast period.
  • By vehicle type, it is estimated that electric/hybrid vehicles would surge at a CAGR of 13.5% during the assessment period.
  • By application, the safety & control segment is estimated to broaden at a CAGR of 15.4% in the next ten years
  • By end user, the automotive aftermarket vendors segment is projected to elevate at a CAGR of 13.2% in the next ten years.
  • Japan automotive semiconductors market is predicted to showcase a CAGR of 14.0% during the estimated period.

“East Asia automotive semiconductors market is anticipated to expand rapidly during the forecast period. It is as a result of rising demand for connected automobile, autonomous driving, and advanced driver assistance systems (ADAS) technology.” – Says a lead analyst.

Electrification of Vehicles to Catapult Automotive Semiconductor Sales in East Asia

Demand for semiconductors is increasing among both electric vehicles (EVs) and hybrid electric vehicles (HEVs) manufacturers. Sales of conventional automobiles are also increasing due to the implementation of government regulations to reduce emissions and surge fuel efficiency.

There is a significant opportunity to cut carbon dioxide (CO2) emissions in the existing context of conventional internal combustion engines (ICEs). In order to run an engine powerfully and make significant changes, various of controls and sensors are required.

For instance, in order to reduce CO2 emissions, the government of China plans to implement 6A emission requirements by 2020. Further advancements in the electrification of power trains are necessary for HEV or EV developments.

Governments of various countries across East Asia are in process of completely banning ICE-based vehicles. It is further enabling China to aim to increase EV production through automakers.

Several automakers have a target to have EVs account for more than 20% of their sales within 10 years. It is projected to drastically increase the production of EVs. As leading OEMs achieve EV production goals, the semiconductor landscape is expected to broaden significantly.

Competitive Landscape

Automotive semiconductor manufacturers in East Asia are embracing digitalization by implementing advanced technologies such as artificial intelligence, big data, and the internet of things. They are aiming to improve the efficiency and quality of their products & production processes.

A few other manufacturers are strengthening their partnerships with automakers. They are striving to ensure that their products meet specific needs of each automaker. They are also aiming to improve the integration of their products with vehicle designs.

For instance,

  • NXP Semiconductors and Volkswagen established a strategic partnership in October 2020. Both companies are aiming to provide advanced driver assistance systems (ADAS) and autonomous driving solutions.

East Asia Automotive Semiconductors Market Outlook by Category

By Product:

  • Processors
  • Sensors
  • Integrated Circuits
  • Discrete Devices
  • Memory Units
  • Others

By Vehicle Type:

  • Fuel-based Vehicles
    • Passenger Cars
    • Commercial Vehicles
  • Electric/Hybrid Vehicles
    • Passenger Cars
    • Commercial Vehicles

By Application:

  • Powertrain
  • Safety & Control
  • Vehicle Body Electronics
  • Chassis
  • Telemetric and Infotainment

By End User:

  • Automotive Manufacturers/OEMs
  • Automotive Aftermarket Vendors

Country:

  • China
  • Japan
  • South Korea

Get a Sample PDF of the Report. https://www.futuremarketinsights.com/reports/sample/rep-gb-17107

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries. Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.

Contact Us:      

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Automated Breast Ultrasound Systems Market Poised to Reach USD 7.23 Billion by 2033 at a 14% of CAGR

Automated Breast Ultrasound Systems Market
Automated Breast Ultrasound Systems Market

The global automated breast ultrasound systems (ABUS) market, valued at approximately US$ 1.95 billion in 2023, is projected to experience substantial growth, reaching an estimated US$ 7.23 billion by 2033. This expansion is driven by a robust compound annual growth rate (CAGR) of 14% over the forecast period.

Automated breast ultrasound systems have emerged as a crucial tool in breast cancer screening, offering enhanced imaging capabilities compared to traditional mammography, especially for patients with dense breast tissue. The increasing prevalence of breast cancer, combined with rising awareness of early detection and advancements in ultrasound technology, is fueling demand for ABUS worldwide.

As healthcare providers prioritize patient comfort, accuracy, and early cancer detection, automated breast ultrasound systems are gaining traction as a preferred screening option. The technology’s user-friendly interface and ability to generate 3D images provide radiologists with more detailed insights, which can lead to improved diagnostic accuracy and treatment outcomes.

ABUS offers several advantages over conventional methods, such as providing 3D images and reducing the dependency on operator expertise, leading to improved diagnostic accuracy and efficiency. Additionally, advancements in artificial intelligence and machine learning have further enhanced ABUS’s capabilities, enabling automated lesion detection and characterization.

The market has also been bolstered by the rising adoption of digital healthcare solutions and telemedicine, allowing for remote interpretation and consultation, thereby improving access to healthcare services for patients in remote areas. Moreover, increased investments in research and development have resulted in the launch of more sophisticated and user-friendly ABUS devices, encouraging their widespread adoption among healthcare providers.

However, challenges persist, such as the high cost of ABUS equipment, which may limit its accessibility in certain regions. Moreover, despite the benefits, there remains a need for continued education and training of medical professionals to ensure optimal utilization of ABUS technology.

Key Takeaways from FMI’s Automated Breast Ultrasound Systems Market Study:

  • Increasing government investment to promote breast cancer awareness among women will bolster demand across the U.S.
  • The U.K is expected to experience noteworthy growth as governments and private organizations aim at curbing high mortality rate due to breast cancer.
  • Presence of modern healthcare infrastructure will increase automated breast ultrasound system adoption across Germany
  • Saudi Arabia will offer lucrative opportunities owing to rapid urbanization and emergence of advance diagnostics centers.
  • India is expected to exhibit increasing demand owing to increase in per capita income and to growing incidence of breast cancer among women.
  • Hospitals are expected to lead the market driven by faster accessibility modern tool and availability of skilled professionals.

What are the Major Challenges Hindering the Automated Breast Ultrasound Systems Market?

A radiologist with expertise in ABUS is required to correctly interpret the volumetric 3D images and identify the region of the breast lesion. The lack of skilled radiologists and the increased cost of standardized training hamper the market growth.

Lack of awareness in emerging economies regarding breast cancer and underdeveloped healthcare infrastructure in underdeveloped countries are also hindering the market growth.

According to Winship Cancer Institute, breast ultrasound is more susceptible to producing false positives than mammography. The breast ultrasound system is also not equipped to indicate whether the tumor is benign or cancerous. The inability to display calcification among women above 45 years is a major concern among the market players.

Automated Breast Ultrasound Systems – Competitive Landscape

Key market players in the automated breast ultrasound system market are focusing on installing ABUS in hospitals and diagnostics centers to expand their global footprint. They are also working towards developing the accuracy of automated breast ultrasound systems for faster cancer screening assessment and getting government approval for their products.

Key players are investing heavily in research and development activities to develop essential and improved products. These players are adopting various market methodologies such as mergers, acquisitions, product launches, collaborations, and partnerships. They are distributing their products with local and international suppliers to reach relevant audiences to increase sales volume.

Other Essential Players in the Global Market are:

  • GE Healthcare
  • Hitachi Ltd
  • SonoCine Inc
  • Philips Healthcare
  • Siemens Healthineers
  • Supersonic Imagine
  • Toshiba Corporation
  • QT Ultrasound LLC
  • Adaltis S.r.l.
  • Volpara Health Technologies
  • Delphinus Medical Technologies, Inc
  • General Electric Company
  • Hologic, Inc
  • Telemed Systems, Inc

Recent Developments in the Global Market are:

  • Hitachi being the global leader in smart life & eco-friendly systems launched its latest automated breast ultrasound system “SOFIA” capable of scanning and acquiring images of the complete breast.
  • Koninklijke launched Philips EPIQ and Affiniti ultrasound systems as a part of its automated breast ultrasound system product range. Philips EPIQ is laced with an integrated eL18-4 transducer and employs anatomical intelligence for accurate imaging of the breast with high tissue density.
  • Siemens Healthineers AG introduced a new automated breast ultrasound system “ACUSON S2000 ABVS” as a part of its imaging, diagnostics segment with a 3D imaging feature required to find the lesions in fatty and dense breast tissue.

Automated breast ultrasound system named “AWBUS” made by SonoCiné is capable of providing repeated scans of the whole breast with the same consistency and accuracy necessary for the accurate detection of cancer.

A Comprehensive Full Report

Automated Breast Ultrasound Systems Market by Category

By End User:

  • Hospitals
  • Diagnostic Imaging Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube